In-vivo and in-vitro biocompatibility evaluations of silver nanoparticles with antimicrobial activity

Journal of Nanoscience and Nanotechnology

Volumn 12, Issue 7, 2012, Pages 5205-5209

  Han, Dong Wook ^a   Woo, Yeon I ^b   Lee, Mi Hee ^b   Lee, Jong Ho ^a   Lee, Jaebeom ^a   Park, Jong Chul ^b  

^a Pusan National University   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Antimicrobial Effect; Biocompatibility; Silver Nanoparticles

Indexed keywords

ACUTE TOXICITY; AMES TEST; ANIMAL MODEL; ANTI-MICROBIAL ACTIVITY; ANTI-MICROBIAL EFFECTS; ANTIBACTERIAL EFFECTS; AVERAGE DIAMETER; BACTERIAL STRAINS; CYTOTOXIC; GENOTOXICITIES; IN-VITRO; IN-VIVO; MINIMUM INHIBITORY CONCENTRATION; PSEUDOMONAS AERUGINOSA; REVERSE MUTATION; SALMONELLA TYPHIMURIUM; SILVER NANOPARTICLES; STAPHYLOCOCCUS AUREUS;

BACTERIOLOGY; BIOCOMPATIBILITY; CYTOTOXICITY; ESCHERICHIA COLI; MICROORGANISMS; NANOPARTICLES; SALMONELLA; TOXICITY;

SILVER;

ANTIINFECTIVE AGENT; BIOMATERIAL; METAL NANOPARTICLE;

ANIMAL; ARTICLE; BACTERIAL PHENOMENA AND FUNCTIONS; CHO CELL; CRICETULUS; DRUG EFFECT; HAMSTER; LD 50; MATERIALS TESTING; MOUSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL PHYSIOLOGICAL PHENOMENA; BIOCOMPATIBLE MATERIALS; CHO CELLS; CRICETINAE; CRICETULUS; LETHAL DOSE 50; MATERIALS TESTING; METAL NANOPARTICLES; MICE;

EID: 84865112758     PISSN: 15334880     EISSN: 15334899     Source Type: Journal    
DOI: 10.1166/jnn.2012.6367     Document Type: Article

References (22)

1. P. V. AshaRani, G. Low Kah Mun, M. P. Hande, and S. Valiyaveettil, ACS Nano 3, 279 (2009).
2. B. J. Dair, D. M. Saylor, T. E. Cargal, G. R. French, K. M. Kennedy, R. S. Casas, J. E. Guyer, J. A. Warren, C. S. Kim, and S. K. Pollack, J. Nanosci. Nanotechnol. 10, 8456 (2010).
3. S. Hwang and S. Jeong, J. Nanosci. Nanotechnol. 11, 610 (2011).
4. V. P. Singh, A. Katiyar, and S. Singh, Biometals 21, 491 (2008).
5. Z. C. Xing, W. P. Chae, J. Y. Baek, M. J. Choi, Y. Jung, and I. K. Kang, Biomacromolecules 11, 1248 (2010).
6. D. Li, J. Diao, J. Zhang, and J. Liu, J. Nanosci. Nanotechnol. 11, 4733 (2011).
7. U. Samuel and J. P. Guggenbichler, Int. J. Antimicrob. Agents 23, S75 (2004).
8. L. Zhao, H. Wang, K. Huo, L. Cui, W. Zhang, H. Ni, Y. Zhang, Z. Wu, and P. K. Chu, Biomaterials 32, 5706 (2011).
9. D.-W. Han, M. S. Lee, M. H. Lee, M. Uzawa, and J.-C. Park, World J. Microbiol. Biotechnol. 21, 921 (2005).
10. B. N. Ames, J. McCann, and E. Yamasaki, Mutation Res. 31, 347 (1975).
11. D. M. Maron and B. N. Ames, Mutation Res. 113, 173 (1983).
12. Clinical and Laboratory Standards Institute, Methods for Determining Bactericidal Activity of Antimicrobial Agents, Approved Guideline, CLSI document M26-A, Wayne, PA, USA (1999).
13. K. Kawata, M. Osawa, and S. Okabe, Environ. Sci. Technol. 43, 6046 (2009).
14. L. Wei, J. Tang, Z. Zhang, Y. Chen, G. Zhou, and T. Xi, Biomed. Mater. 5, 044103 (2010).
15. E. J. Park, J. Yi, Y. Kim, K. Choi, and K. Park, Toxicol. In Vitro 24, 872 (2010).
16. M. A. Franco-Molina, E. Mendoza-Gamboa, C. A. Sierra-Rivera, R. A. Gómez-Flores, P. Zapata-Benavides, P. Castillo-Tello, J. M. Alcocer-González, D. F. Miranda-Hernández, R. S. Tamez-Guerra, and C. Rodríguez-Padilla, J. Exp. Clin. Cancer Res. 29, 148 (2010).
17. P. V. Asharani, M. P. Hande, and S. Valiyaveettil, BMC Cell Biol. 10, 65 (2009)
18. A. Kumar, A. K. Pandey, S. S. Singh, R. Shanker, and A. Dhawan, Chemosphere 83, 1124 (2011).
19. S. Y. Liau, D. C. Read, W. J. Pugh, J. R. Furr, and A. D. Russell, Lett. Appl. Microbiol. 25, 279 (1997).
20. B. Jansen, M. Rinck, P. Wolbring, A. Strohmeier, and T. Jahns, J. Biomater. Appl. 9, 55 (1994).
21. Q. L. Feng, J. Wu, G. Q. Chen, F.-Z. Cui, T. N. Kim, and J. O. Kim, J. Biomed. Mater. Res. 52, 662 (2000).
22. A. Wadhera and M. Fung, Dermatol. Online J. 11, 12 (2005).